STENTYS Information

View Top Employees from STENTYS

STENTYS | 2,997 followers on LinkedIn | STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents.

Website	http://www.stentys.com
Ticker	STNT
Revenue	$9 million
Employees	21 (0 on RocketReach)
Founded	2006
Address	8 Rue d Hauteville, Paris, Ile-de-France 75010, FR
Phone	+33 1 44 53 99 42
Fax	+33 1 44 53 99 24
Technologies	G Suite , Gmail , Slack +3 more (view full list)
Industry	Medical Devices, Medical Devices & Equipment, Health Care, Stent, Design, Manufacturing, Health Diagnostics, Coronary Artery Disease, Medical Device, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter
Web Rank	8 Million
Keywords	Drug Eluting Stents, Interventional Cardiology, Vascular Intervention, Peripheral Artery Disease, Coronary Artery Disease, Stent Technology, Atherosclerosis Treatment, Endovascular Devices, Medical Devices, Heart Disease Treatment, Angioplasty, Cardiology Technology, Minimally Invasive Surgery, Vascular Surgery
Competitors	Siemens Healthineers, Johnson & Johnson, Medtronic, Abbott, Philips, Cordis, Boston Scientific, Cardinal Health, BIOTRONIK, Terumo +30 more (view full list)
SIC	SIC Code 384 Companies, SIC Code 38 Companies
NAICS	NAICS Code 33 Companies, NAICS Code 339 Companies